These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 342081)

  • 1. Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histiocytic lymphomas.
    Mattsson W; von Eyben F; Turesson I; Wählby S
    Cancer; 1978 Jan; 41(1):112-6. PubMed ID: 342081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic lymphocytic leukemia and lymphosarcoma with a new chlorambucil ester of prednisolone (Leo 1031) (NSC-134087).
    Aungst CW; Mittelman A; Murphy GP
    J Surg Oncol; 1975; 7(6):457-60. PubMed ID: 1102806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma.
    Johnsson JE; Tropé C; Mattsson W; Grundsell H; Aspegren K; Könyves I
    Cancer Treat Rep; 1979 Mar; 63(3):421-4. PubMed ID: 371798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous treatment of non-Hodgkin's malignant lymphoma with prednimustine (Leo 1031).
    Håkansson L; Könyves I; Lindberg LG; Möller T
    Oncology; 1978; 35(3):103-6. PubMed ID: 673314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
    Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednimustine treatment in malignant lymphomas.
    Szántó I; Fleischmann T; Eckhardt S
    Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
    Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
    Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
    Biomedicine; 1977 Jun; 27(4):158-61. PubMed ID: 329910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
    Schein PS; Chabner BA; Canellos GP; Young RC; DeVita VT
    Cancer; 1975 Feb; 35(2):354-7. PubMed ID: 1089470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of chlorambucil and streptonigrin (NSC-45383) in the treatment of malignant lymphomas.
    Kaung DT; Wittington RM; Spencer H; Patno ME
    Cancer; 1969 Jun; 23(6):1280-3. PubMed ID: 4890442
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma.
    Móller TR; Brandt L; Kónyves I; Lindberg G
    Acta Med Scand; 1975 Apr; 197(4):323-7. PubMed ID: 1173538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
    Juul K; Sørensen P; Pedersen-Bjergaard J; Jensen MK
    Scand J Haematol; 1979 Nov; 23(5):388-92. PubMed ID: 396664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
    Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia].
    Lutz D; Böhnel J
    Osterr Z Onkol; 1977; 3(5-6):155-9. PubMed ID: 323777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prednimustine in treatment of acute leukemia in elderly patients].
    Brandt L; Könyves I
    Lakartidningen; 1977 Apr; 74(15):1490-3. PubMed ID: 321896
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
    Loos U; Musch E; Malek M; Riedel E
    Oncology; 1991; 48(4):334-42. PubMed ID: 1891177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
    Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
    Nouv Presse Med; 1976 Nov; 5(38):2525-30. PubMed ID: 790316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary clinical study of prednimustine in lung cancer.
    Catane H; Catane R; Takita H; Kaufman JH; Mittelman A; Murphy GP
    J Med; 1977; 8(2):115-21. PubMed ID: 268397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
    Gandara DR; Wold HG; Redmond J; Kohler M; Reynolds R; Wong P; Forsythe J; Fisher K; Lewis B
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):14-8. PubMed ID: 3952517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of Leo 1031, an alkylating corticosteroid ester, in lymphoproliferative disorders. I. chronic lymphocytic leukaemia.
    Brandt L; Kónyves I; Móller TR
    Acta Med Scand; 1975 Apr; 197(4):317-22. PubMed ID: 1136862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.